Octant

Octant Bio

This company develops small molecule drugs for patients with protein misfolding diseases using high-throughput synthetic biology, generative chemistry and machine learning.

Accent Therapeutics

This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.

Actio Biosciences

This biotechnology company develops small molecule medicines to treat rare genetic diseases and common conditions for patients with high unmet medical needs.

Vividion

The company develops small-molecule medicines for patients with cancer and immune disorders using a proprietary chemoproteomics platform to target previously undruggable proteins.

Septerna, Inc

This biotechnology company develops small-molecule medicines targeting G protein-coupled receptors to treat patients with endocrine, inflammatory and metabolic diseases.

Alterome Therapeutics

This company develops small-molecule targeted therapies for cancer patients by using computational chemistry to address specific genetic mutations.

Scenic Biotech

This company develops disease-modifying small molecule therapeutics for patients with rare genetic and neurodegenerative disorders using its proprietary genetic modifier discovery platform.

Enodia

This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.